Whatever happened to thrombopoietin?-Reference-Cited by-同舟云学术

Whatever happened to thrombopoietin?

Published:2002-03 Issue:3 Volume:42 Page:279-283
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Kuter David J.¹

Affiliation:

1. Hematology Unit Massachusetts General Hospital Harvard Medical School 100 Blossom Street Boston, MA 02114

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1537-2995.2002.00056.x

Reference48 articles.

1. Thrombopoietin

2. Kuter DJ. Thrombopoietin. In: Durum SK Hirano T Vilcek J Nicola NA eds. Cytokine reference: a compendium of cytokines and other mediators of host defense. New York: Academic Press 2000.

3. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin.

4. Thrombocytopenia in c-mpl-deficient mice

5. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The structure, function, and clinical use of the thrombopoietin receptor agonist avatrombopag;Blood Reviews;2021-11

Romiplostim for the Treatment of Immune Thrombocytopenia: Spotlight on Patient Acceptability and Ease of Use

;Patient Preference and Adherence;2020-07

3. Diversity, novelty and satisfactoriness in health innovation;Journal of Evolutionary Economics;2019-05-08

4. Current Advance in Thrombopoietin Receptor Agonists in the Management of Thrombocytopenia Associated With Chronic Liver Disease: Focus on Avatrombopag;Clinical Medicine Insights: Blood Disorders;2019-01

5. Eltrombopag for use in children with immune thrombocytopenia;Blood Advances;2018-02-27